#USA #Raleigh #LabConnect #Clinical Trials #SampleGISTICS

LabConnect Launches SampleGISTICS® 2.0

LabConnect, a leading global provider of central laboratory services and functional service solutions for clinical trials, has unveiled its latest innovation, SampleGISTICS® 2.0. This advanced application is poised to streamline and digitize the process of collecting and managing clinical trial samples, making life easier for researchers and participants alike.

A New Era for Clinical Trials

With the new SampleGISTICS® 2.0 app, clinical research sites can now easily scan, capture, and transmit sample information from participants using a smartphone or tablet. This innovative approach replaces the outdated digital pen technology previously used by LabConnect, effectively modernizing the sample collection and data entry processes at the collection sites.

The development of SampleGISTICS 2.0 is based on data drawn from millions of samples collected during global clinical trials, ensuring that the app addresses longstanding challenges faced by researchers. Eliminating the reliance on paper forms, manual data entry, and isolated courier processes can considerably reduce the risk of sample loss, delays in shipment, and a lack of operational transparency.

Expert Insights

“This system is a culmination of over two decades of our experience in managing decentralized clinical studies within our extensive lab network, courier services, and operational departments,” said Wes Wheeler, CEO of LabConnect. “Our expertise allowed us to create an application tailored to the specific needs of clinical trials, facilitating a more efficient digital sample collection process at the point of origin.”

Furthermore, SampleGISTICS 2.0 provides real-time visibility into sample status, location, and stability, from collection right through to laboratory acceptance. The app incorporates study protocol-aligned workflows that minimize data entry errors and ensure correct kit usage, thereby facilitating downstream shipping and laboratory processes.

Features That Empower Users

Some of the key features of SampleGISTICS 2.0 include barcode scanning, multilingual support, and offline functionality, which enable consistent performance across diverse site environments. The ability to document data on the same day as sample collection improves adherence to protocols, ensuring researchers can maintain accurate and timely records.

Charles Castano, LabConnect's Chief Technology Officer, elaborated on the app's benefits, stating, “SampleGISTICS 2.0 simplifies the handling of study visit and participant data collected on-site, securely transferring it into LabConnect’s validated LIMS environment. By optimizing on-site data collection through technology, we significantly reduce inquiries and gain important insights into samples approaching expiration, ensuring they are prioritized. This, in turn, decreases manual processes and promotes faster, more reliable laboratory results.”

Conclusion

In a landscape where clinical trials must navigate increasing complexity and stringent regulatory requirements, innovations like SampleGISTICS® 2.0 offer invaluable support for researchers and participants. By adopting cutting-edge technology, LabConnect facilitates more effective management of clinical samples, showcasing their commitment to improving outcomes and operational efficiency in the field of clinical research.

For more information about LabConnect and SampleGISTICS® 2.0, visit LabConnect.com.
For those invested in the success of clinical trials, this new tool represents a significant leap forward in ensuring that vital research can be conducted more smoothly and efficiently.